The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension.

Obese individuals frequently develop hypertension, which is for an important part attributable to renin-angiotensin-aldosterone system (RAAS) overactivity. This review summarizes preclinical and clinical evidence on the involvement of dysfunctional adipose tissue in RAAS activation and on the renal, central, and vascular mechanisms linking RAAS components to obesity-associated hypertension.

[1]  H. Lithell,et al.  Alterations in skeletal muscle morphology in glucose‐tolerant elderly hypertensive men: relationship to development of hypertension and heart rate , 2000, Journal of hypertension.

[2]  G. Adler,et al.  Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-&ggr;, and Proinflammatory Adipokines , 2008, Circulation.

[3]  Azra Mahmud,et al.  Review: Arterial stiffness and the renin-angiotensin-aldosterone system , 2004 .

[4]  T. Saruta,et al.  Electrophysiological Properties of Rostral Ventrolateral Medulla Neurons in Angiotensin II 1a Receptor Knockout Mice , 2005, Hypertension.

[5]  R. M. Lee,et al.  Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II. , 2010, European journal of pharmacology.

[6]  M. Mendelsohn,et al.  Angiotensin II and Aldosterone Regulate Gene Transcription Via Functional Mineralocortocoid Receptors in Human Coronary Artery Smooth Muscle Cells , 2005, Circulation research.

[7]  R. Schmieder,et al.  Aldosterone-induced cardiac damage: focus on blood pressure independent effects. , 2003, American journal of hypertension.

[8]  E. Schiffrin,et al.  Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent Pathways , 2007, Hypertension.

[9]  V. V. van Hinsbergh,et al.  Insulin-induced changes in skeletal muscle microvascular perfusion are dependent upon perivascular adipose tissue in women , 2015, Diabetologia.

[10]  I. Reid.  Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. , 1992, The American journal of physiology.

[11]  A. Ferreira,et al.  Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. , 2013, The Journal of endocrinology.

[12]  C. Caruso-Neves,et al.  The angiotensin receptor type 1–Gq protein–phosphatidyl inositol phospholipase Cβ–protein kinase C pathway is involved in activation of proximal tubule Na+‐ATPase activity by angiotensin(1–7) in pig kidneys , 2008, Experimental physiology.

[13]  J. Loscalzo,et al.  Aldosterone Inactivates the Endothelin-B Receptor via a Cysteinyl Thiol Redox Switch to Decrease Pulmonary Endothelial Nitric Oxide Levels and Modulate Pulmonary Arterial Hypertension , 2012, Circulation.

[14]  R. Santos,et al.  Brain-Selective Overexpression of Human Angiotensin-Converting Enzyme Type 2 Attenuates Neurogenic Hypertension , 2010, Circulation research.

[15]  K. Sunagawa,et al.  Sympathoinhibitory effects of telmisartan through the reduction of oxidative stress in the rostral ventrolateral medulla of obesity-induced hypertensive rats , 2012, Journal of hypertension.

[16]  J. van de Voorde,et al.  Adipose Tissue as Regulator of Vascular Tone , 2012, Current Hypertension Reports.

[17]  J. Stern,et al.  Compromised blood–brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension , 2016, The Journal of physiology.

[18]  V. Demarco,et al.  Vascular stiffness in insulin resistance and obesity , 2015, Front. Physiol..

[19]  R. Widdop,et al.  Angiotensin-(1–7) Acts as a Vasodepressor Agent Via Angiotensin II Type 2 Receptors in Conscious Rats , 2005, Hypertension.

[20]  R. Schmieder,et al.  Rapid Nongenomic Effects of Aldosterone on the Renal Vasculature in Humans , 2006, Hypertension.

[21]  J. Sowers,et al.  NADPH Oxidase Contributes to Vascular Inflammation, Insulin Resistance, and Remodeling in the Transgenic (mRen2) Rat , 2007, Hypertension.

[22]  N. Naing,et al.  The effects of angiotensin II on pulse wave velocity in healthy humans. , 2009, International journal of clinical pharmacology and therapeutics.

[23]  W. Kannel,et al.  Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. , 1987, Preventive medicine.

[24]  R. Touyz,et al.  Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction , 2012, Hypertension.

[25]  K. Sandberg,et al.  Reduction of plasma aldosterone and arterial stiffness in obese pre- and stage1 hypertensive subjects after aerobic exercise , 2014, Journal of Human Hypertension.

[26]  W. White,et al.  Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension , 2003, Hypertension.

[27]  G. Tangelder,et al.  Renal microvascular actions of angiotensin II fragments. , 2002, American journal of physiology. Renal physiology.

[28]  D. Webb,et al.  Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man , 2001, The Journal of physiology.

[29]  R. Evans,et al.  Renal sympathetic activation from long-term low-dose angiotensin II infusion in rabbits , 2012, Journal of hypertension.

[30]  A. Ferguson,et al.  Circulating signals as critical regulators of autonomic state--central roles for the subfornical organ. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[31]  T. Tagawa,et al.  AT(1) receptors mediate excitatory inputs to rostral ventrolateral medulla pressor neurons from hypothalamus. , 1999, Hypertension.

[32]  Michael E. Hall,et al.  Catheter-based radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs. , 2014, American journal of hypertension.

[33]  A. Pries,et al.  Microcirculation in Hypertension: A New Target for Treatment? , 2001, Circulation.

[34]  T. Hussain,et al.  Renal Angiotensin II Type-2 Receptors Are Upregulated and Mediate the Candesartan-Induced Natriuresis/Diuresis in Obese Zucker Rats , 2005, Hypertension.

[35]  M. Schambelan,et al.  The tissue renin‐angiotensin system in rats with fructose‐ induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue , 2000, Journal of hypertension.

[36]  Yiling Fu,et al.  Mineralocorticoid-Induced Sodium Appetite and Renal Salt Retention: Evidence for Common Signaling and Effector Mechanisms , 2014, Nephron Physiology.

[37]  K. Rahmouni,et al.  Prolonged treatment with angiotensin 1–7 improves endothelial function in diet-induced obesity , 2013, Journal of hypertension.

[38]  J. Bains,et al.  ACTIONS OF ANGIOTENSIN IN THE SUBFORNICAL ORGAN AND AREA POSTREMA: IMPLICATIONS FOR LONG TERM CONTROL OF AUTONOMIC OUTPUT , 1997, Clinical and experimental pharmacology & physiology.

[39]  C. de Ciuceis,et al.  Blockade of the renin–angiotensin system in small arteries and anticontractile function of perivascular adipose tissue , 2015, Journal of hypertension.

[40]  K. Sunagawa,et al.  Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats , 2012, Hypertension Research.

[41]  C. Stehouwer,et al.  Impaired Microvascular Function in Obesity: Implications for Obesity-Associated Microangiopathy, Hypertension, and Insulin Resistance , 2004, Circulation.

[42]  T. Hussain,et al.  AT2 receptor non-peptide agonist C21 promotes natriuresis in obese Zucker rats , 2012, Hypertension Research.

[43]  A. Heagerty,et al.  Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target , 2012, British journal of pharmacology.

[44]  A. A. da Silva,et al.  Aldosterone Antagonism Attenuates Obesity-Induced Hypertension and Glomerular Hyperfiltration , 2004, Hypertension.

[45]  A. Johnson,et al.  Central endogenous angiotensin-(1-7) protects against aldosterone/NaCl-induced hypertension in female rats. , 2013, American journal of physiology. Heart and circulatory physiology.

[46]  J. Webster,et al.  Angiotensin II. Adrenergic sympathetic constrictor action in humans. , 1995, Circulation.

[47]  L. Rosivall,et al.  Angiotensin II directly stimulates macula densa Na-2Cl-K cotransport via apical AT(1) receptors. , 2002, American journal of physiology. Renal physiology.

[48]  D. Warnock,et al.  Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. , 2002, Journal of the American Society of Nephrology : JASN.

[49]  J. Menani,et al.  Hindbrain mineralocorticoid mechanisms on sodium appetite. , 2013, American journal of physiology. Regulatory, integrative and comparative physiology.

[50]  Eric Vicaut,et al.  Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus , 2008, Circulation.

[51]  R. Santos,et al.  Angiotensin (1-7) Induces Mas Receptor Internalization , 2011, Hypertension.

[52]  H. Struijker‐Boudier,et al.  Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases , 2003, Circulation.

[53]  P. Dagnelie,et al.  Age, waist circumference, and blood pressure are associated with skin microvascular flow motion: The Maastricht Study , 2014, Journal of hypertension.

[54]  E. Schiffrin,et al.  Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells , 2007, Hypertension.

[55]  Arya M. Sharma,et al.  The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? , 2003, The international journal of biochemistry & cell biology.

[56]  R. Kreutz,et al.  Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue. , 2008, The Journal of endocrinology.

[57]  J. T. ter Maaten,et al.  Impaired Skin Capillary Recruitment in Essential Hypertension Is Caused by Both Functional and Structural Capillary Rarefaction , 2001, Hypertension.

[58]  G. Sesti,et al.  Angiotensin II Impairs the Insulin Signaling Pathway Promoting Production of Nitric Oxide by Inducing Phosphorylation of Insulin Receptor Substrate-1 on Ser312 and Ser616 in Human Umbilical Vein Endothelial Cells , 2004, Circulation research.

[59]  N. Toda,et al.  Aldosterone affects blood flow and vascular tone regulated by endothelium‐derived NO: therapeutic implications , 2013, British journal of pharmacology.

[60]  Meredith J. Luttrell,et al.  Mineralocorticoid receptors modulate vascular endothelial function in human obesity. , 2013, Clinical science.

[61]  C. Acampora,et al.  Effects of Losartan and Chlorthalidone on Blood Pressure and Renal Vascular Resistance Index in Non-Diabetic Patients with Essential Hypertension and Normal Renal Function , 2004, Journal of cardiovascular pharmacology.

[62]  K. Nakao,et al.  Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. , 2010, American journal of hypertension.

[63]  J. Yudkin,et al.  Insulin's microvascular vasodilatory effects are inversely related to peripheral vascular resistance in overweight, but insulin‐sensitive subjects , 2013, Obesity.

[64]  C. Stehouwer,et al.  Visceral and truncal subcutaneous adipose tissue are associated with impaired capillary recruitment in healthy individuals. , 2006, The Journal of clinical endocrinology and metabolism.

[65]  O. Krizanova,et al.  Rat epididymal fat tissue express all components of the renin-angiotensin system. , 2000, General physiology and biophysics.

[66]  J. Frisbee.  Hypertension‐Independent Microvascular Rarefaction in the Obese Zucker Rat Model of the Metabolic Syndrome , 2005, Microcirculation.

[67]  C. Caruso-Neves,et al.  Angiotensin-(1–7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na+-ATPase activity via a A779-sensitve receptor , 2002, Regulatory Peptides.

[68]  K. Griendling,et al.  Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. , 2007, American journal of physiology. Cell physiology.

[69]  C. Gomez-Sanchez,et al.  Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. , 1990, The American journal of physiology.

[70]  A. Heagerty,et al.  Mechanisms of adiponectin-associated perivascular function in vascular disease. , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[71]  J. T. ter Maaten,et al.  Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. , 1999, Circulation.

[72]  J. Fitzsimons,et al.  The association of thirst, sodium appetite and vasopressin release with c-fos expression in the forebrain of the rat after intracerebroventricular injection of angiotensin II, angiotensin-(1–7) or carbachol , 1995, Neuroscience.

[73]  A. Kroon,et al.  Aldosterone-Renin Ratio and Side-Selective Renal Perfusion in Essential Hypertension. , 2016, American journal of hypertension.

[74]  J. Twisk,et al.  Body mass index is related to microvascular vasomotion, this is partly explained by adiponectin , 2014, European journal of clinical investigation.

[75]  D. Randall,et al.  Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[76]  B. Viollet,et al.  Perivascular Adipose Tissue Control of Insulin-Induced Vasoreactivity in Muscle Is Impaired in db/db Mice , 2013, Diabetes.

[77]  S. Nedogoda,et al.  Randomized Trial of Perindopril, Enalapril, Losartan and Telmisartan in Overweight or Obese Patients with Hypertension , 2013, Clinical Drug Investigation.

[78]  Y-B Zhou,et al.  Superoxide anions modulate the effects of angiotensin-(1–7) in the rostral ventrolateral medulla on cardiac sympathetic afferent reflex and sympathetic activity in rats , 2012, Neuroscience.

[79]  Zhenqi Liu,et al.  Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In Vivo , 2011, Diabetes.

[80]  G. Adler,et al.  Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects , 2014, Diabetes, obesity & metabolism.

[81]  B. Del-Río-Navarro,et al.  Effect of Losartan on Vascular Function in Fructose-Fed Rats: The Role of Perivascular Adipose Tissue , 2010, Clinical and experimental hypertension.

[82]  S. Ko,et al.  Hypertension Management and Microvascular Insulin Resistance in Diabetes , 2010, Current hypertension reports.

[83]  K. Burns,et al.  The role of angiotensin II-stimulated renal tubular transport in hypertension , 2003, Current hypertension reports.

[84]  M. Phillips,et al.  Levels of angiotensin and molecular biology of the tissue renin angiotensin systems , 1993, Regulatory Peptides.

[85]  N. Vaziri,et al.  Upregulation of Angiotensin II Type 1 Receptor, Inflammatory Mediators, and Enzymes of Arachidonate Metabolism in Obese Zucker Rat Kidney: Reversal by Angiotensin II Type 1 Receptor Blockade , 2005, Circulation.

[86]  L. Cassis,et al.  Characterization of renin activity in brown adipose tissue. , 1997, The American journal of physiology.

[87]  G. Kajiyama,et al.  Effects of Angiotensin-(1-7) on Forearm Circulation in Normotensive Subjects and Patients With Essential Hypertension , 2001, Hypertension.

[88]  Jason D. Fowler,et al.  Regulated renin release from 3T3-L1 adipocytes. , 2009, American journal of physiology. Endocrinology and metabolism.

[89]  C. Stehouwer,et al.  Microvascular Dysfunction: A Potential Mechanism in the Pathogenesis of Obesity‐associated Insulin Resistance and Hypertension , 2012, Microcirculation.

[90]  J. Hall,et al.  Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. , 1999, Journal of the American Society of Nephrology : JASN.

[91]  J. Paton,et al.  Baroreflex inhibition of cardiac sympathetic outflow is attenuated by angiotensin II in the nucleus of the solitary tract , 2001, Neuroscience.

[92]  S. Coppack,et al.  Insulin-Mediated Upregulation of the Renin Angiotensin System in Human Subcutaneous Adipocytes Is Reduced by Rosiglitazone , 2005, Circulation.

[93]  A. Heagerty,et al.  Obesity-related hypertension: Epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue , 2012, Annals of medicine.

[94]  N. Farman,et al.  The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[95]  W. Rascher,et al.  Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. , 1992, The Journal of pharmacology and experimental therapeutics.

[96]  G. Schmid-Schönbein,et al.  Enhancement of Glucocorticoid and Mineralocorticoid Receptor Density in the Microcirculation of the Spontaneously Hypertensive Rat , 2004, Microcirculation.

[97]  C. Ecelbarger,et al.  Aldosterone infusion with high-NaCl diet increases blood pressure in obese but not lean Zucker rats. , 2006, American journal of physiology. Renal physiology.

[98]  C. Stehouwer,et al.  Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. , 2007, Physiology.

[99]  M. Campagnole-Santos,et al.  Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. , 1992, The American journal of physiology.

[100]  H. Tomita,et al.  Aldosterone causes vasoconstriction in coronary arterioles of rats via angiotensin II type-1 receptor: influence of hypertension. , 2007, European journal of pharmacology.

[101]  E. Barrett,et al.  Angiotensin-(1–7) Recruits Muscle Microvasculature and Enhances Insulin’s Metabolic Action via Mas Receptor , 2014, Hypertension.

[102]  J. Sowers,et al.  Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet–Induced Arterial Stiffening in Female Mice , 2015, Hypertension.

[103]  Young Yang,et al.  A novel adipokine CTRP1 stimulates aldosterone production , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  M. Raizada,et al.  Overexpression of Angiotensin-Converting Enzyme 2 in the Rostral Ventrolateral Medulla Causes Long-Term Decrease in Blood Pressure in the Spontaneously Hypertensive Rats , 2007, Hypertension.

[105]  T. Matsukawa,et al.  Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. , 1991, The American journal of physiology.

[106]  G. Mancia,et al.  Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study , 2003, Journal of hypertension.

[107]  C. Stehouwer,et al.  Physiological hyperinsulinaemia increases intramuscular microvascular reactive hyperaemia and vasomotion in healthy volunteers , 2004, Diabetologia.

[108]  V. Achard,et al.  Renin receptor expression in human adipose tissue. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[109]  C. Ferrario,et al.  Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[110]  M. Brody,et al.  Role of central mineralocorticoid binding sites in development of hypertension. , 1990, The American journal of physiology.

[111]  S. Umemura,et al.  Modulation of tissue angiotensinogen gene expression in genetically obese hypertensive rats. , 1997, The American journal of physiology.

[112]  K. Sunagawa,et al.  Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome , 2012, Journal of hypertension.

[113]  Meredith J. Luttrell,et al.  Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adults , 2016, Experimental Gerontology.

[114]  M. Emdin,et al.  Microvascular responses to aldosterone in hamster cheek pouch microcirculation. , 2013, Clinical hemorheology and microcirculation.

[115]  Reinder Evertz,et al.  Direct evidence for insulin-induced capillary recruitment in skin of healthy subjects during physiological hyperinsulinemia. , 2002, Diabetes.

[116]  K. Sutton-Tyrrell,et al.  Serum Aldosterone Is Associated with Inflammation and Aortic Stiffness in Normotensive Overweight and Obese Young Adults , 2012, Clinical and experimental hypertension.

[117]  Lina Zhao,et al.  Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment. , 2013, American journal of physiology. Endocrinology and metabolism.

[118]  J. Hall,et al.  Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. , 1986, The American journal of physiology.

[119]  F. Ruschitzka,et al.  Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity , 2013, European heart journal.

[120]  De-Pei Li,et al.  Angiotensin II Attenuates Synaptic GABA Release and Excites Paraventricular-Rostral Ventrolateral Medulla Output Neurons , 2005, Journal of Pharmacology and Experimental Therapeutics.

[121]  Eric Lazartigues,et al.  Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II–Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor Downregulation , 2008, Circulation research.

[122]  R. Muniyappa,et al.  Metabolic actions of angiotensin II and insulin: A microvascular endothelial balancing act , 2013, Molecular and Cellular Endocrinology.

[123]  G. Sesti,et al.  Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs. , 2013, Cardiovascular research.

[124]  D. Averill,et al.  Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II andL-glutamate in rostral ventrolateral medulla , 1994, Brain Research.

[125]  P. D. de Leeuw,et al.  Angiotensin II enhances insulin-stimulated whole-body glucose disposal but impairs insulin-induced capillary recruitment in healthy volunteers. , 2010, The Journal of clinical endocrinology and metabolism.

[126]  A. Sugawara,et al.  Nongenomic vascular action of aldosterone in the glomerular microcirculation. , 2003, Journal of the American Society of Nephrology : JASN.

[127]  J. Blacher,et al.  Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. , 1997, American journal of hypertension.

[128]  A. Nishiyama,et al.  Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. , 2007, Journal of the American Society of Nephrology : JASN.

[129]  J. Morrow,et al.  Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. , 2004, American journal of hypertension.

[130]  J. Sowers,et al.  The pathophysiology of hypertension in patients with obesity , 2014, Nature Reviews Endocrinology.

[131]  Z. Fortes,et al.  Upregulation of ERK1/2-eNOS via AT2 Receptors Decreases the Contractile Response to Angiotensin II in Resistance Mesenteric Arteries from Obese Rats , 2014, PloS one.

[132]  Yu-Ming Kang,et al.  Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats. , 2008, American journal of physiology. Heart and circulatory physiology.

[133]  Jia Liu,et al.  Candesartan acutely recruits skeletal and cardiac muscle microvasculature in healthy humans. , 2012, The Journal of clinical endocrinology and metabolism.

[134]  W. Spiering,et al.  Mechanisms linking obesity to hypertension , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[135]  R. Iliescu,et al.  Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function , 2008, Hypertension.

[136]  O. Carretero,et al.  Vasodilator Action of Angiotensin-(1-7) on Isolated Rabbit Afferent Arterioles , 2002, Hypertension.

[137]  L. Cassis,et al.  Angiotensin Converting Enzyme 2 Contributes to Sex Differences in the Development of Obesity Hypertension in C57BL/6 Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[138]  C. D. A. Stehouwer,et al.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease , 2008, Diabetologia.

[139]  J. Filosa,et al.  Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis , 2015, Circulation.

[140]  G. Giacchetti,et al.  Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. , 2002, American journal of hypertension.

[141]  R. Klein,et al.  Retinal vascular caliber and the development of hypertension: a meta-analysis of individual participant data , 2014, Journal of hypertension.

[142]  David L. Brown,et al.  Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials). , 2007, The American journal of cardiology.

[143]  R. M. Lee,et al.  Endothelium-dependent relaxation factor released by perivascular adipose tissue , 2009, Journal of hypertension.

[144]  Daniel Levy,et al.  Aortic stiffness, blood pressure progression, and incident hypertension. , 2012, JAMA.

[145]  R. Kwong,et al.  Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes , 2014, Diabetes.

[146]  R. Charnigo,et al.  Adipocyte Deficiency of Angiotensinogen Prevents Obesity-Induced Hypertension in Male Mice , 2012, Hypertension.

[147]  A. Ferguson,et al.  Subfornical organ neurons projecting to paraventricular nucleus: whole-cell properties , 2001, Brain Research.

[148]  S. Laurent,et al.  The structural factor of hypertension: large and small artery alterations. , 2015, Circulation research.

[149]  Michael E. Hall,et al.  Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. , 2015, Circulation research.

[150]  Hui Chen,et al.  Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells* , 2003, Journal of Biological Chemistry.

[151]  J. Loscalzo,et al.  Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity , 2007, Nature Medicine.

[152]  D. Lyn,et al.  Eplerenone suppresses aldosterone/ salt-induced expression of NOX-4 , 2011, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[153]  E. Barrett,et al.  Obesity Blunts Insulin-Mediated Microvascular Recruitment in Human Forearm Muscle , 2006, Diabetes.

[154]  C. Caruso-Neves,et al.  Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7). , 2006, The Biochemical journal.

[155]  L. Sjöström,et al.  Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. , 1998, The Journal of clinical endocrinology and metabolism.

[156]  B. Balkau,et al.  Hypertension and vascular dynamics in men and women with metabolic syndrome. , 2013, Journal of the American College of Cardiology.

[157]  E. Schiffrin,et al.  Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling , 2003, Hypertension.

[158]  B. Jensen,et al.  Rapid actions of aldosterone in vascular health and disease--friend or foe? , 2006, Pharmacology & therapeutics.

[159]  A. Loewy,et al.  Aldosterone in the brain. , 2009, American journal of physiology. Renal physiology.

[160]  D. Rizzoni,et al.  Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. , 2008, The Journal of clinical endocrinology and metabolism.

[161]  M. G. Cogan,et al.  Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. , 1990, Hypertension.

[162]  P. Challande,et al.  Smooth Muscle Cell Mineralocorticoid Receptors Are Mandatory for Aldosterone–Salt to Induce Vascular Stiffness , 2014, Hypertension.

[163]  Azra Mahmud,et al.  Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension. , 2005, American journal of hypertension.

[164]  Leptin and aldosterone in sympathetic activity in resistant hypertension with or without type 2 diabetes. , 2012, Arquivos brasileiros de cardiologia.

[165]  J. Loscalzo,et al.  Aldosterone Increases Oxidant Stress to Impair Guanylyl Cyclase Activity by Cysteinyl Thiol Oxidation in Vascular Smooth Muscle Cells* , 2009, Journal of Biological Chemistry.

[166]  D. Diz,et al.  Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7). , 1995, Hypertension.

[167]  C Bogardus,et al.  Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. , 1987, The Journal of clinical investigation.

[168]  F. Gao,et al.  Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling. , 2010, European journal of pharmacology.

[169]  M. Campagnole-Santos,et al.  Evidence that angiotensin-(1–7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors , 1994, Brain Research.

[170]  R. Britto,et al.  Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats. , 1997, Hypertension.

[171]  E. Schiffrin,et al.  Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients , 2008, Hypertension.

[172]  R. Santos,et al.  Blockade of endogenous angiotensin-(1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone. , 2005, Hypertension.

[173]  R. Carey,et al.  Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes. , 1993, The American journal of physiology.

[174]  M. Campagnole-Santos,et al.  Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats. , 1996, Hypertension.

[175]  I. Zucker,et al.  Microinjection of ANG II into paraventricular nucleus enhances cardiac sympathetic afferent reflex in rats. , 2002, American journal of physiology. Heart and circulatory physiology.

[176]  Arya M. Sharma,et al.  Weight Loss and the Renin-Angiotensin-Aldosterone System , 2005, Hypertension.

[177]  G. Giacchetti,et al.  Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects , 2002, Journal of endocrinological investigation.

[178]  L. Tallam,et al.  Significance Of Exaggerated Natriuresis After Angiotensin AT1 Receptor Blockade Or Angiotensin‐ Converting Enzyme Inhibition In Obese Zucker Rats , 2001, Clinical and experimental pharmacology & physiology.

[179]  H. Oberleithner,et al.  The role of ENaC in vascular endothelium , 2013, Pflügers Archiv - European Journal of Physiology.

[180]  F. Jessen,et al.  Early-Onset and Late-Onset Depression Are Independent of the Genetic Polymorphism of Apolipoprotein E , 1999, Dementia and Geriatric Cognitive Disorders.

[181]  J. T. ter Maaten,et al.  Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. , 2001, Cardiovascular research.

[182]  N. Martell,et al.  Characterization of angiotensin-(1-7) in the urine of normal and essential hypertensive subjects. , 1998, American journal of hypertension.

[183]  A. Schreihofer,et al.  Altered regulation of the rostral ventrolateral medulla in hypertensive obese Zucker rats. , 2011, American journal of physiology. Heart and circulatory physiology.

[184]  Yen-Hung Lin,et al.  Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. , 2012, Atherosclerosis.

[185]  S. Davidge,et al.  Angiotensin-Converting Enzyme 2 Is a Critical Determinant of Angiotensin II–Induced Loss of Vascular Smooth Muscle Cells and Adverse Vascular Remodeling , 2014, Hypertension.

[186]  K. Monahan,et al.  Aldosterone impairs baroreflex sensitivity in healthy adults. , 2007, American journal of physiology. Heart and circulatory physiology.

[187]  R. Iliescu,et al.  Systemic and Renal‐Specific Sympathoinhibition in Obesity Hypertension , 2011, Hypertension.

[188]  J. Maly,et al.  Effect of Intrarenal Infusion of Angiotensin–(1–7) in the Dog , 2000, Kidney and Blood Pressure Research.

[189]  J. Sowers,et al.  Mineralocorticoid Receptor Antagonism Treats Obesity-Associated Cardiac Diastolic Dysfunction , 2015, Hypertension.

[190]  I. Kowalik,et al.  Postprocedural TIMI flow grade 2 in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary revascularization. (PL-ACS Registry) , 2013 .

[191]  W. Mayhan,et al.  Angiotensin-mediated increase in renal sympathetic nerve discharge within the PVN: role of nitric oxide. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[192]  B. Adams-Huet,et al.  Spironolactone Prevents Chlorthalidone-Induced Sympathetic Activation and Insulin Resistance in Hypertensive Patients , 2012, Hypertension.

[193]  R. M. Lee,et al.  Alterations in perivascular adipose tissue structure and function in hypertension. , 2011, European journal of pharmacology.

[194]  M. Safar,et al.  Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated Rats: Effects of Eplerenone , 2002, Circulation.

[195]  A. Nishiyama,et al.  Aldosterone Suppresses Insulin Signaling Via the Downregulation of Insulin Receptor Substrate-1 in Vascular Smooth Muscle Cells , 2007, Hypertension.

[196]  J. Francis,et al.  ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. , 2011, Cardiovascular research.

[197]  P. D. de Leeuw,et al.  Acute angiotensin II receptor blockade improves insulin-induced microvascular function in hypertensive individuals. , 2011, Microvascular research.

[198]  C. Stehouwer,et al.  Microvascular dysfunction as a link between obesity, insulin resistance and hypertension. , 2014, Diabetes research and clinical practice.

[199]  K. Sunagawa,et al.  Role of Angiotensin-(1-7) in Rostral Ventrolateral Medulla in Blood Pressure Regulation via Sympathetic Nerve Activity in Wistar-Kyoto and Spontaneous Hypertensive Rats , 2011, Clinical and experimental hypertension.

[200]  Cynthia A. Reinhart-King,et al.  Arterial Stiffening Precedes Systolic Hypertension in Diet-Induced Obesity , 2013, Hypertension.

[201]  C. Kahn,et al.  Cross-talk between the insulin and angiotensin signaling systems. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[202]  R. Santos,et al.  Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. , 2003, American journal of physiology. Heart and circulatory physiology.

[203]  C. Gomez-Sanchez,et al.  Central regulation of blood pressure by the mineralocorticoid receptor , 2012, Molecular and Cellular Endocrinology.

[204]  M. Campagnole-Santos,et al.  Central and peripheral actions of angiotensin-(1-7). , 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[205]  R. Touyz,et al.  Adipocytes, aldosterone and obesity-related hypertension. , 2016, Journal of molecular endocrinology.

[206]  J. Filosa,et al.  Circulating Angiotensin II Gains Access to the Hypothalamus and Brain Stem During Hypertension via Breakdown of the Blood–Brain Barrier , 2014, Hypertension.

[207]  T. Yoshimoto,et al.  Aldosterone induces superoxide generation via Rac1 activation in endothelial cells. , 2008, Endocrinology.

[208]  A. Kroon,et al.  Angiotensin-(1–7)–Induced Renal Vasodilation in Hypertensive Humans Is Attenuated by Low Sodium Intake and Angiotensin II Co-Infusion , 2013, Hypertension.

[209]  M. Romero,et al.  Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7). , 1993, Kidney international.

[210]  S. Umemura,et al.  Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man. , 2000, Hypertension.

[211]  I. Jaffe,et al.  Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease , 2013, Pflügers Archiv - European Journal of Physiology.

[212]  S. Millasseau,et al.  Relations between large artery structure and function and aldosterone. , 2011, Journal of hypertension.

[213]  A. Kroon,et al.  Angiotensin-(1-7) as a strategy in the treatment of hypertension? , 2014, Current opinion in nephrology and hypertension.

[214]  M. Campagnole-Santos,et al.  Modulation of the baroreflex control of heart rate by angiotensin‐(1–7) at the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats , 2000, Journal of hypertension.

[215]  R. Henning,et al.  The role of angiotensin(1–7) in renal vasculature of the rat , 2006, Journal of hypertension.

[216]  G. Nguyen,et al.  Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. , 2002, The Journal of clinical investigation.

[217]  J. Connell,et al.  The new biology of aldosterone. , 2005, The Journal of endocrinology.

[218]  P. Schling,et al.  Human Adipose Tissue Cells Keep Tight Control on the Angiotensin II Levels in Their Vicinity* , 2002, The Journal of Biological Chemistry.

[219]  J. Peti-Peterdi,et al.  Angiotensin II stimulates macula densa basolateral sodium/hydrogen exchange via type 1 angiotensin II receptors. , 1999, Journal of the American Society of Nephrology : JASN.

[220]  A. Stanton,et al.  Pharmacological Modulation of Arterial Stiffness , 2011, Drugs.

[221]  P. Schling,et al.  Evidence for a local renin angiotensin system in primary cultured human preadipocytes , 1999, International Journal of Obesity.

[222]  S. Engeli,et al.  Co-expression of renin-angiotensin system genes in human adipose tissue. , 1999, Journal of hypertension.

[223]  M. Safar,et al.  Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[224]  N. Martell,et al.  Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension , 1996, Journal of hypertension.

[225]  P. Arner,et al.  Increased adipose angiotensinogen gene expression in human obesity. , 2000, Obesity research.

[226]  J. Strandhoy,et al.  Renal actions of angiotensin-(1-7): in vivo and in vitro studies. , 1996, The American journal of physiology.

[227]  E. Barrett,et al.  Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. , 2007, American journal of physiology. Endocrinology and metabolism.

[228]  M. Barton,et al.  Obesity and risk of vascular disease: importance of endothelium‐dependent vasoconstriction , 2012, British journal of pharmacology.

[229]  A. Dupont,et al.  Brain angiotensin peptides regulate sympathetic tone and blood pressure , 2010, Journal of hypertension.